Intuitive Surgical, Inc. (LON:0R29)
London · Delayed Price · Currency is GBP · Price in USD | Market Cap | 155.02B |
| Revenue (ttm) | 7.15B |
| Net Income (ttm) | 2.04B |
| Shares Out | n/a |
| EPS (ttm) | 5.62 |
| PE Ratio | 75.86 |
| Forward PE | 62.12 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 529 |
| Average Volume | 1,062 |
| Open | 585.58 |
| Previous Close | 585.84 |
| Day's Range | 579.80 - 589.50 |
| 52-Week Range | 406.50 - 616.00 |
| Beta | 1.67 |
| RSI | 59.92 |
| Earnings Date | Jan 21, 2026 |
About Intuitive Surgical
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling,... [Read more]
Financial Performance
In 2024, Intuitive Surgical's revenue was $8.35 billion, an increase of 17.24% compared to the previous year's $7.12 billion. Earnings were $2.32 billion, an increase of 29.18%.
Financial numbers in USD Financial StatementsNews
Intuitive Surgical (ISRG): Bernstein Raises Price Target to $740 | ISRG Stock News
Intuitive Surgical (ISRG): Bernstein Raises Price Target to $740 | ISRG Stock News
Intuitive Surgical: An Easy 'Buy And Hold' For Long-Term Outperformance
Can da Vinci 5 Expand Intuitive Surgical's TAM Beyond Core Surgeries?
ISRG is positioning da Vinci 5 as a TAM expander, targeting cardiac surgery long term while advancing near-term regulatory steps in general surgery.
February 27th Options Now Available For Intuitive Surgical (ISRG)
Investors in Intuitive Surgical Inc (Symbol: ISRG) saw new options begin trading today, for the February 27th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the IS...
ISRG: Barclays Raises Price Target and Maintains Overweight Rating | ISRG Stock News
ISRG: Barclays Raises Price Target and Maintains Overweight Rating | ISRG Stock News
BTIG Maintains "Buy" on ISRG, Raises Price Target to $616 | ISRG Stock News
BTIG Maintains "Buy" on ISRG, Raises Price Target to $616 | ISRG Stock News
Is ISRG Stock Still A Buy At $600?
ISRG stock has climbed nearly 40% from its October 2025 lows of approximately $425, currently trading near $590. What has spurred this remarkable rise?
ISRG Trading 4% Below All-Time High: Should You Buy the Stock Now?
ISRG trades just 4% below its record high after a 32% surge over the past three months, driven by strong procedure growth, rising utilization, and early traction for the da Vinci 5 system.
Is This Robotic Surgery Titan the Secret to 100% Gains by 2030?
Intuitive Surgical is a leading provider of surgical robotics devices. Its da Vinci robot was one of the first to market and boasts a massive installed base.
$100 Invested In Intuitive Surgical 20 Years Ago Would Be Worth This Much Today
Intuitive Surgical (NASDAQ: ISRG) has outperformed the market over the past 20 years by 11.68% on an annualized basis producing an average annual return of 20.44%. Currently, Intuitive Surgical has a...
Top Robotics Stocks That Could Drive Impressive Returns in 2026
Robotics is poised for steady growth in 2026. Consider PATH, NVDA, CDNS and ISRG for potential market dominance across sectors.
The Zacks Analyst Blog Eli Lilly, Medtronic, Intuitive Surgical, Regeneron Pharmaceuticals and Johnson & Johnson
Eli Lilly highlights how AI is transforming healthcare, from drug discovery to diagnostics, turning defensive medical stocks into growth plays for 2026.
2 Soaring Stocks to Hold for the Next 20 Years
If you are looking for growth stocks that have solid long-term prospects, Costco and Intuitive Surgical should be on your short list.
My 10 Top Stocks to Buy to Start the New Year Off Right
This selection of stocks offers interesting buys throughout industries -- from tech to healthcare. Many of these players are trading at bargain levels.
Watch 5 AI-Powered Medical Stocks for a Strong Portfolio in 2026
LLY, MDT, ISRG, REGN and JNJ are five defensive medical stocks using AI to drive growth, diagnostics and innovation into 2026.
This Robotic Surgery Pioneer Could Be Worth $1 Million for Long-Term Holders
Intuitive Surgical is a pioneer in robotic-assisted surgery. Despite increasing competition, its innovative ability and strong moat should help protect its market share.
Prediction: These 2 Growth Stocks Will Beat the Market Through 2031
Several factors could help Intuitive Surgical's stock soar through 2031, despite recent challenges. Meta Platforms' results might justify its AI investments.
Where Will Intuitive Surgical Be in 5 Years?
Demand for Intuitive Surgical's da Vinci surgical robot is growing faster than the company's sales of new robots.
SCHG, ISRG, DIS, LIN: Large Outflows Detected at ETF
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Schwab U.S. Large-Cap Growth ETF (Symbol: SCHG) where we have detected...
AI Integration In MedTech Devices And Diagnostics: Regulation And Investment Opportunities
Medical technology is experiencing a paradigm shift as artificial intelligence moves from experimental labs into operating rooms and diagnostic centers worldwide. What once sounded like science fictio...
Interesting ISRG Put And Call Options For February 2026
Investors in Intuitive Surgical Inc (Symbol: ISRG) saw new options begin trading today, for the February 2026 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the IS...
ISRG Sees 91% SP Growth: A Turning Point for Single-Port Surgery?
ISRG's single-port platform posts 91% procedure growth, led by Korea, with U.S. momentum building as new tools and indications expand adoption.
Zacks Industry Outlook Highlights Veracyte, IDEXX Laboratories and Intuitive Surgical
Veracyte stands out in a pressured medical instruments industry as genAI adoption and rising sales forecasts fuel investor interest.
Here Are My Top 2 No-Brainer Growth Stocks to Buy Now
These healthcare growth stocks are profitable and revenue is growing at a double-digit pace. Intuitive Surgical is the top global player in the field of robotic surgery.
Palantir, Nvidia Lead 5 Stocks Near Buy Points Heading Into Final Days Of 2025
Palantir, Nvidia and Intuitive Surgical are among stocks to watch setting up as the market gets ready to close out 2025.